Analyzing 5N Plus (FPLSF) and Its Peers

5N Plus (OTCMKTS:FPLSFGet Free Report) is one of 297 publicly-traded companies in the “Chemicals” industry, but how does it compare to its rivals? We will compare 5N Plus to similar businesses based on the strength of its risk, valuation, analyst recommendations, earnings, profitability, dividends and institutional ownership.

Insider & Institutional Ownership

0.1% of 5N Plus shares are owned by institutional investors. Comparatively, 47.6% of shares of all “Chemicals” companies are owned by institutional investors. 3.9% of 5N Plus shares are owned by company insiders. Comparatively, 13.8% of shares of all “Chemicals” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares 5N Plus and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
5N Plus 14.14% 26.36% 11.28%
5N Plus Competitors -60.57% -10.75% -1.28%

Analyst Ratings

This is a breakdown of recent recommendations for 5N Plus and its rivals, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
5N Plus 0 1 2 1 3.00
5N Plus Competitors 3212 12196 14214 500 2.40

As a group, “Chemicals” companies have a potential upside of 10.01%. Given 5N Plus’ rivals higher possible upside, analysts clearly believe 5N Plus has less favorable growth aspects than its rivals.

Volatility and Risk

5N Plus has a beta of 1.86, indicating that its stock price is 86% more volatile than the S&P 500. Comparatively, 5N Plus’ rivals have a beta of 1.23, indicating that their average stock price is 23% more volatile than the S&P 500.

Earnings and Valuation

This table compares 5N Plus and its rivals gross revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
5N Plus $391.06 million $50.57 million 26.16
5N Plus Competitors $6.33 billion $216.27 million -4.81

5N Plus’ rivals have higher revenue and earnings than 5N Plus. 5N Plus is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Summary

5N Plus beats its rivals on 8 of the 13 factors compared.

About 5N Plus

(Get Free Report)

5N Plus Inc. produces and sells specialty metals and chemicals in North America, Europe, and Asia. It operates through two segments, Specialty Semiconductors and Performance Materials. The company offers semiconductor compounds, semiconductor wafers, metals, epitaxial semiconductor substrates, and solar cells. It also provides active pharmaceutical ingredients, animal feed additives, specialized chemicals, commercial grade metals, alloys, engineered powders, and recycling services. The company serves renewable energy, security, space, pharmaceutical, medical imaging, manufacturing, electronic, consumer, and industrial application markets. 5N Plus Inc. is headquartered in Montreal, Canada.

Receive News & Ratings for 5N Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 5N Plus and related companies with MarketBeat.com's FREE daily email newsletter.